Introduction to Drugs and Pharmacy
MODULE 5: PHARMACEUTICS (17.5%)
- Manufacturing Pharmacy
- Pharmaceutical Dosage Forms
- Physical Pharmacy
- Jurisprudence and Ethics
CHAPTER 1: INTRODUCTION TO DRUGS & PHARMACY
|
|||
Drug
|
agent intended for USE, MITIGATION, TREATMENT, CURE, OR
PREVENTION of siease in humans or other animals
|
||
Pharmakon
|
Greek Word- charm or durg that may b\e used for good or evil
(Homeric)
|
||
Ebers Papyrus
|
most
famous;continuous 60 ft scroll 16th century
Preserved
in Uni of Leipzig
Named
after Georg Ebers
800 formulas, 700 drugs
|
||
Hippocrates
|
Greek; Oath; FATHER OF MEDICINE
|
||
Dioscoride
|
first
to deal with botany as applied science of pharmacy
De
Materia Medica
|
||
Claudius Galen
|
aimed
to create perfect system of physiology, pathology and treatment
Galen’s
cerate- COLD CREAM
|
||
Emperor Frederick II of Germany
|
kingdom
Two Sicilies
Separation
of pharmacist and physician’s duties
|
||
Paracelsus
Aureolus Theophrastus Bombastus von Hohenheim
|
Swiss
physician
Transformed
from pharmacy as botanical science to chemical science
|
||
Karl Scheele
|
pharmacist
Discovered
lactic acid, citric, oxalic, arsenic etc
Discovered
oxygen before Priestly
|
||
Frederich Serturner
|
Isolation
of Morphine and Opium
|
||
Joseph Caventou
Joseph Pelletier
|
French
Isolated quinine and cinchonine from cinchona
Isolated STRYCHNINE and BRUCINE form nux vomica
|
||
Joseph Pelletier
Pierre Robiquet
|
Isolated CAFFEINE
|
||
Pierre Robiquet
|
Separated CODEINE from Opium
|
||
United States Pharmacopeia (1820)
|
|
||
Philadelphia College
|
1821- First pharmacy school
|
||
Lititz Pharmacopeia (1778)
|
First American Pharmacopeia
|
||
Lyman Spalding (1817)
|
Physician
Inititate creation of pharmacopeia
FATHER OF THE USP
|
||
Durham-Humphrey Amendment 1952
|
Prescription drugs – not be refilled
|
||
Kefauver-Harris Amendment 1962
|
Greater safety of approved drugs
Due to THALIDOMIDE incident
|
||
COMPREHENSIVE DRUG ABUSE PREVENTION AND CONTROL ACT 1970
|
|||
FIVE (5) SCHEDULES
|
|||
I
|
No accepted medical use
High potential for abuse
|
LSD, mescaline, peyote, marijuana
|
|
II
|
Accepted medical
High Abuse
Lead to severe physiologic or physical dependence
|
Morphine, Cocaine, Methamphetamine, Amobarbital
|
|
III
|
Accepted Medical
Less abuse than I & II
Lead to MODERATE…
|
Hydrocodone
CODEINE
|
|
IV
|
Accepted
Low potential abuse than III
Lead to LIMITED…
|
Diazepam, -zepams, diphenoxin
|
|
V
|
Accepted
Low potential abuse than IV
Lead to LIMITED… less than IV
|
Dihydrocodeine
Diphenoxylate
|
|
FDA PREGNANCY CATEGORIES
|
|||
A
|
No risk
|
||
B
|
Animal studies: Failed to see risk
Humans: No adequate studies
|
||
C*
|
Animal: Adverse effect
Human: No adequate studies
|
||
D*
|
Human: Positive evidence of fetal risk
*Potential benefit may outweigh risk
|
||
X
|
FETAL ABNORMALITIES
^never to use in preggies
|
||
Black box warning
|
Describe risk and emphasize close monitoring
|
||
Prescription Drug marketing Act of 1987
|
#No to selling doctor’s samples
|
||
Dietary Supplement Health and Ed Act 1994
|
No to false misleading “uses’ of herbals and botanicals
|
||
Pharmaceutical Care
|
“Component of pharmacy practice which entails the direct
interaction of Px and Rx for the purpose of care in drug related
needs”-Strand etc
“..direct, responsible provision of medication related care for
the purpose of achieving definite outcomes the improves patients quality of
life” ASHSP
|
||
CODE OF ETHICS
|
|||
1. COVENANTAL
relationship bet px & rx
|
Moral obligations in exchange of the society’s trust.
Maintain trust
|
||
0 comments: